These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9815944)

  • 1. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications.
    Tanner MM; Tirkkonen M; Kallioniemi A; Holli K; Collins C; Kowbel D; Gray JW; Kallioniemi OP; Isola J
    Clin Cancer Res; 1995 Dec; 1(12):1455-61. PubMed ID: 9815944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis and gene expression profiling of 20q13-amplified breast cancers.
    Ginestier C; Cervera N; Finetti P; Esteyries S; Esterni B; Adélaïde J; Xerri L; Viens P; Jacquemier J; Charafe-Jauffret E; Chaffanet M; Birnbaum D; Bertucci F
    Clin Cancer Res; 2006 Aug; 12(15):4533-44. PubMed ID: 16899599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes.
    Tanner MM; Tirkkonen M; Kallioniemi A; Collins C; Stokke T; Karhu R; Kowbel D; Shadravan F; Hintz M; Kuo WL
    Cancer Res; 1994 Aug; 54(16):4257-60. PubMed ID: 8044767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.
    Tanner MM; Tirkkonen M; Kallioniemi A; Isola J; Kuukasjärvi T; Collins C; Kowbel D; Guan XY; Trent J; Gray JW; Meltzer P; Kallioniemi OP
    Cancer Res; 1996 Aug; 56(15):3441-5. PubMed ID: 8758909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of 20q13 gain by dual-color FISH in breast cancers.
    Kobayashi Y; Esato K; Noshima S; Oga A; Sasaki K
    Anticancer Res; 2000; 20(1B):531-5. PubMed ID: 10769720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization.
    Weiss MM; Snijders AM; Kuipers EJ; Ylstra B; Pinkel D; Meuwissen SG; van Diest PJ; Albertson DG; Meijer GA
    J Pathol; 2003 Jul; 200(3):320-6. PubMed ID: 12845628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells.
    Savelieva E; Belair CD; Newton MA; DeVries S; Gray JW; Waldman F; Reznikoff CA
    Oncogene; 1997 Feb; 14(5):551-60. PubMed ID: 9053853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of 20q13 gains in sporadic colorectal cancers: a FISH analysis.
    Aust DE; Muders M; Köhler A; Schmidt M; Diebold J; Müller C; Löhrs U; Waldman FM; Baretton GB
    Scand J Gastroenterol; 2004 Aug; 39(8):766-72. PubMed ID: 15513363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
    Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
    Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array.
    Rummukainen JK; Salminen T; Lundin J; Kytölä S; Joensuu H; Isola JJ
    Mod Pathol; 2001 Oct; 14(10):1030-5. PubMed ID: 11598174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer.
    Tanner MM; Grenman S; Koul A; Johannsson O; Meltzer P; Pejovic T; Borg A; Isola JJ
    Clin Cancer Res; 2000 May; 6(5):1833-9. PubMed ID: 10815905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
    Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
    Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 20q13.2 gain may predict intravesical recurrence after nephroureterectomy in upper urinary tract urothelial tumors.
    Akao J; Matsuyama H; Yamamoto Y; Sasaki K; Naito K
    Clin Cancer Res; 2006 Dec; 12(23):7004-8. PubMed ID: 17145821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization.
    Diebold J; Mösinger K; Peiro G; Pannekamp U; Kaltz C; Baretton GB; Meier W; Löhrs U
    J Pathol; 2000 Apr; 190(5):564-71. PubMed ID: 10727982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.
    Yao J; Weremowicz S; Feng B; Gentleman RC; Marks JR; Gelman R; Brennan C; Polyak K
    Cancer Res; 2006 Apr; 66(8):4065-78. PubMed ID: 16618726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
    Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
    Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y; Booser DJ; Sneige N
    Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.
    Courjal F; Theillet C
    Cancer Res; 1997 Oct; 57(19):4368-77. PubMed ID: 9331100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.
    Di Leo A; Gancberg D; Larsimont D; Tanner M; Jarvinen T; Rouas G; Dolci S; Leroy JY; Paesmans M; Isola J; Piccart MJ
    Clin Cancer Res; 2002 May; 8(5):1107-16. PubMed ID: 12006526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
    Rennstam K; Ahlstedt-Soini M; Baldetorp B; Bendahl PO; Borg A; Karhu R; Tanner M; Tirkkonen M; Isola J
    Cancer Res; 2003 Dec; 63(24):8861-8. PubMed ID: 14695203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.